Key result
Exercise during chemotherapy attenuates GLS impairment versus control but shows no LVEF benefit.
Why the study?
Chemotherapy for breast cancer often causes cardiotoxicity that impairs health and quality of life, prompting evaluation of the cardioprotective effects of physical exercise.
Does physical exercise prevent chemotherapy-induced cardiotoxicity in breast cancer patients?
Meta-Analysis
Does physical exercise prevent chemotherapy-induced cardiotoxicity in breast cancer patients?
Exercise training during chemotherapy provides cardioprotection by preserving global longitudinal strain in breast cancer patients.
Answers are grounded in this paper and cite their sources.
Supports exercise to preserve GLS during chemotherapy; extends evidence using sensitive strain markers beyond LVEF.
BACKGROUND: Chemotherapy associated with breast cancer often induces cardiotoxicity, which compromises patients' health and quality of life. OBJECTIVE: To verify the effect of physical exercise on chemotherapy-induced cardiotoxicity, through the assessment of cardiac function in patients with breast cancer. METHODS: A systematic review and meta-analysis of clinical studies was conducted to evaluate the effectiveness of physical training in chemotherapy-induced cardiomyopathy in the PubMed, Web of Sciences and Scopus databases. Thirteen studies were included in the systematic review and eleven studies in the data meta-analysis. RESULTS: Global longitudinal strain presents a cardioprotective effect when compared to the control group (Heterogeneity: Chi² = 12.81, df = 10 (p = 0.23); I² = 22 %.) Test for global effect: Z = 2, 13 (p = 0.03). Physical training is more effective (test for subgroup differences, p = 0.031) in attenuating the impairment of %GLS induced by chemotherapy if performed concomitantly with exposure to chemotherapy (95 % CI; Heterogeneity: Chi² = 7.49, gl = 5 (p = 0.19); I² = 33 %; Test for global effect: Z = 2.33 (p = 0.02) when compared after chemotherapy treatment, or in the long term (for 12 months or more). However, without benefits in LVEF (Heterogeneity: Chi² = 42.14, df = 10 (p < 0.00001); I² = 76 %) Test for global effect: Z = 2.51 (p = 0.01) Conclusion: Exercise training is a cardioprotective approach in breast cancer patients who experience chemotherapy-induced cardiotoxicity. Exercise during exposure to chemotherapy has greater effects on preserving cardiac function.
No takes yet. Share an insight, caveat, or question.
Linhares et al. (2024) conducted a meta-analysis in Breast cancer. Physical exercise vs. Control group was evaluated on Global longitudinal strain (GLS) (Z = 2.13, p=0.03). Physical exercise during chemotherapy attenuated the impairment of global longitudinal strain compared to control, but showed no benefit for LVEF.
Synapse has enriched 10 related papers. Consider them for comparative context: